Tea Reljic

ORCID: 0000-0003-2029-6753
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acute Myeloid Leukemia Research
  • Health Systems, Economic Evaluations, Quality of Life
  • Hematopoietic Stem Cell Transplantation
  • Traumatic Brain Injury Research
  • Lymphoma Diagnosis and Treatment
  • Clinical practice guidelines implementation
  • Acute Lymphoblastic Leukemia research
  • Chronic Lymphocytic Leukemia Research
  • Cardiac Arrest and Resuscitation
  • Meta-analysis and systematic reviews
  • Multiple Myeloma Research and Treatments
  • Chronic Myeloid Leukemia Treatments
  • Heart Failure Treatment and Management
  • T-cell and Retrovirus Studies
  • Trauma and Emergency Care Studies
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Cutaneous lymphoproliferative disorders research
  • Ethics in Clinical Research
  • Statistical Methods in Clinical Trials
  • Neutropenia and Cancer Infections
  • Tuberculosis Research and Epidemiology
  • Protein Degradation and Inhibitors
  • Childhood Cancer Survivors' Quality of Life
  • Esophageal Cancer Research and Treatment
  • Traumatic Brain Injury and Neurovascular Disturbances

University of South Florida
2016-2025

Florida College
2010-2022

James A. Haley Veterans' Hospital
2020

Regional Cancer Center
2019

University of Tampa
2017-2018

Evidence Based Research (United States)
2017

Moffitt Cancer Center
2014

De Montfort University
2014

Indiana University Northwest
2014

Center for Outcomes Research in Liver Diseases
2013

According to the threshold model, when faced with a decision under diagnostic uncertainty, physicians should administer treatment if probability of disease is above specified and withhold otherwise. The objectives present study are a) evaluate act according b) examine which existing models [expected utility theory model (EUT), regret-based or dual-processing theory] explains physicians' decision-making best. A survey employing realistic clinical vignettes for patients pulmonary embolism...

10.1186/1472-6947-14-47 article EN cc-by BMC Medical Informatics and Decision Making 2014-06-05

In older patients with acute myeloid leukemia, the more frequent presence of biologically inherent therapy-resistant disease and increased comorbidities translate to poor overall survival therapeutic challenges. Optimal front-line therapies for leukemia remain controversial. We retrospectively evaluated outcomes in 980 elderly (≥70 years) from a single institution between 1995 2016. Four treatment categories were compared: high-intensity (daunorubicin/cytarabine or equivalent),...

10.3324/haematol.2018.208637 article EN cc-by-nc Haematologica 2019-05-09

Background Decision-making relies on both analytical and emotional thinking. Cognitive reasoning styles (e.g. maximizing satisficing tendencies) heavily influence processes, while affective processes are often dependent regret. The relationship between regret cognitive has not been well studied in physicians, is the focus of this paper. Methods A questionnaire 6 scales measuring individual differences (maximizing-satisficing tendencies; vs. intuitive reasoning; need for cognition;...

10.1371/journal.pone.0134038 article EN cc-by PLoS ONE 2015-08-04

Background. Patient outcomes critically depend on accuracy of physicians’ judgment, yet little is known about individual differences in cognitive styles that underlie judgments. The objective this study was to assess relative age, experience, and degree type training. Methods. Physicians at different levels training career completed a web-based survey 6 scales measuring (maximizing v. satisficing, analytical intuitive reasoning, need for cognition, intolerance toward ambiguity, objectivism,...

10.1177/0272989x14525855 article EN Medical Decision Making 2014-04-10

Background: Cytokine release storm (CRS) in severe acute respiratory syndrome coronavirus-2 (SARS CoV-2) is thought to be the cause for organ damage and death which independent of actual viral burden. Tocilizumab (TCZ), an interleukin-6 receptor antagonist, approved treatment CRS. We describe efficacy safety TCZ SARS CoV-2 pneumonia. Methods: This retrospective study was conducted at a tertiary care hospital from April 20 2020 May 21 2020. The primary endpoint cumulative incidence composite...

10.4103/ijmm.ijmm_20_298 article EN Indian Journal of Medical Microbiology 2020-01-01
Coming Soon ...